|Bid||4.7700 x 1000|
|Ask||4.9700 x 1100|
|Day's Range||4.8700 - 5.1600|
|52 Week Range||4.2400 - 6.5500|
|Beta (5Y Monthly)||1.26|
|PE Ratio (TTM)||11.63|
|Earnings Date||Mar 29, 2022 - Apr 04, 2022|
|Forward Dividend & Yield||0.48 (10.69%)|
|Ex-Dividend Date||Apr 08, 2022|
|1y Target Est||6.75|
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th \- 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Spring into Action: VIRTUAL begins on Monday, May 16th, 2022, with a Biotech Discovery Day.
BRANFORD, CT / ACCESSWIRE / May 12, 2022 / Sachem Capital Corp. ("Sachem Corp" or the "Company") (NYSE American:SACH), today announced that Bill Haydon, Chief Investment Officer and Director of Sachem, has been invited to present at the Spring Into Action - Best Ideas Investor Conference, which is being held virtually on May 16th - 20th, 2022.
BRANFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) announces the closing of its previously announced registered public offering of $27.5 million aggregate principal amount of 7.125% unsecured, unsubordinated notes due 2027 (“Notes”). The net proceeds of the offering are estimated to be approximately $26.3 million after payment of underwriting discounts and commissions and estimated offering expenses payable by the company. Sachem has granted the underwri